Press Releases April 28, 2026 04:15 PM

Spectral AI Schedules 2026 First Quarter Financial Results and Conference Call

Spectral AI schedules Q1 2026 financial results release and conference call.

By Jordan Park MDAI
Spectral AI Schedules 2026 First Quarter Financial Results and Conference Call
MDAI

Spectral AI, an AI company focusing on medical diagnostics in wound care, announced that it will report its first quarter 2026 financial results on May 12, 2026, followed by a conference call. The company aims to revolutionize wound care with its DeepView System, which provides predictive diagnostics for burn patients to improve treatment decisions, outcomes, and reduce healthcare costs.

Key Points

  • Spectral AI will report Q1 2026 financial results after Nasdaq close on May 12, 2026, with a conference call to discuss outcomes.
  • The company's DeepView System uses AI for predictive diagnostics in burn wound care, aiming to improve treatment accuracy and reduce costs.
  • Spectral AI was recognized by TIME as one of the World’s Top HealthTech companies in 2025, highlighting its innovation in healthcare technology.

DALLAS, April 28, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the first quarter ended March 31, 2026 on Tuesday, May 12, 2026 after the close of the Nasdaq stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time on the same day to discuss its financial results.

Investors interested in participating in the live call can dial into the conference call as follows:

  • 833-890-6620 – U.S.
  • 412-564-3789 – International

In addition, a simultaneous webcast of the financial results call may be accessed online from the Events section of the Investor Relations page of the Company’s website at https://investors.spectral-ai.com/news-events/events.

About Spectral AI

Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView System. The DeepView System is being developed as a predictive diagnostic device to offer clinicians an objective and immediate assessment of a burn wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of exceeding the current standard of care in the future, the DeepView System is expected to provide fast and accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. Spectral AI has been named to TIME’s list of World’s Top HealthTech companies 2025. For more information about the DeepView System, visit www.spectral-ai.com.

Forward-Looking Statements

Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements. 

Investors should carefully consider the foregoing factors, and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the US Securities and Exchange Commission, including the Company’s Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. 

Investors: 
The Equity Group  Devin Sullivan
Managing Director 
[email protected]
Conor Rodriguez
Associate
[email protected]



Risks

  • Forward-looking statements involve uncertainties including market adoption of AI diagnostics and regulatory approvals impacting performance.
  • The company faces risks related to competition and technological advancements in the medical AI sector.
  • Financial results may vary due to factors outside the company's control, including healthcare industry shifts and funding availability.

More from Press Releases

Fiverr Announces First Quarter 2026 Results Apr 29, 2026 Nayax to Report 2026 Q1 Earnings on May 12, 2026 Apr 28, 2026 Xunlei Filed Its Annual Report on Form 20-F for Fiscal Year 2025 Apr 28, 2026 Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Apr 28, 2026 Syntec Optics (Nasdaq: OPTX) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock Apr 28, 2026